Reaction

Red Blood Cell Sedimentation Rate reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 278 reports · 47 co-occurring drugs

As of the last recalculation, Red Blood Cell Sedimentation Rate appears in 278 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is FEBUXOSTAT TABLETS 40 MG (PRR 1,464.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Febuxostat Tablets 40 Mg1161,464.91,481.9
Febuxostat Tablets 80 Mg1161,464.91,481.9
Dimenhydrinate1151,377.41,392.5
Febuxostat1291,074.31,082.7
Sulfasalazine212851.3853.6
Leflunomide219734.6736.1
Adalimumab-Fkjp167674.5677.0
Colchicine128673.5676.8
Adalimumab-Aaty167660.1662.5
Adalimumab-Adaz167591.9593.8
Tocilizumab208539.1540.1
Ibuprofen And Diphenhydramine Citrate91434.7436.4
Hydroxychloroquine Sulfate181424.4425.3
Abatacept205419.3419.9
Dexlansoprazole115351.4352.4
Infliximab219350.1350.5
Golimumab157313.6314.2
Rituximab211306.9307.2
Alendronate Sodium162286.7287.1
Diclofenac Potassium, Film Coated28276.9277.8
Diclofenac Potassium Tablets28276.7277.6
Risedronate Sodium76251.6252.2
Certolizumab Pegol161243.0243.3
Diclofenac Potassium28215.6216.2
Calcium Gluconate28193.3193.8
Naproxen116189.0189.3
Cortisone Acetate28188.7189.1
Ustekinumab127170.2170.4
Desoximetasone37167.6167.9
Diphenhydramine Hydrochloride Capsule, Liquid Filled35140.2140.4
Apremilast130124.1124.2
Etanercept218122.7122.7
Tofacitinib143118.5118.5
Cyclosporine107116.4116.5
Naproxen Sodium117105.1105.2
Hydroxychloroquine76104.5104.6
Secukinumab11793.093.1
Oxycodone11476.776.7
Pseudoephedrine Hydrochloride1075.575.6
Pseudoephedrine Hcl1070.470.5
Diclofenac Sodium 1%2865.165.2
Diclofenac Sodium Topical2865.165.2
Diclofenac Sodium Topical Gel, 1%2865.065.1
Alendronate Sodium Tablet1459.559.6
Cetirizine Hydrochloride Allergy2053.253.2
Cetirizine Hydrochloride Tablets2053.253.2
Canakinumab642.442.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.